“Use of Cholecystokinin-Octapeptide for the Prevention of Parenteral Nutrition-Associated Cholestasis”
- Daniel H. Teitelbaum, MD SNAP 8
He earned his medical degree at the Ohio State College of Medicine in 1983.
Daniel H. Teitelbaum has a MD, Medicine from the The Ohio State University College of Medicine. Daniel H. Teitelbaum, MD currently works at the University of Michigan and has 10 years experience in researching Parenteral Nutrition-Associated Cholestasis at the University of Michigan. One of their notable works include "Use of Cholecystokinin-Octapeptide for the Prevention of Parenteral Nutrition-Associated Cholestasis". Published online May 2005. doi:https://doi.org/10.1542/peds.2004-1014 [PubMed]
Medicine at Michigan | Michigan Medicine | Research Gate
Estimated Reading Time: < 1 min read
Related Posts
- Humicein‐like peptide endowed
“A novel rat gene encoding a Humicein‐like peptide endowed with broad neuroprotective activity”1 1. Caricasole…
- Innovative New Treatment
“DermaFracTM: An Innovative New Treatment for Periorbital Melanosis in a Dark‑Skinned Male Patient”1 1. Kassir…
- DSIP peptide and glucocorticoid‐induced
“Delta sleep‐inducing peptide and glucocorticoid‐induced leucine zipper: potential links between circadian mechanisms and obesity?”1 1.…
- The peptide semax affects
“The peptide semax affects the expression of genes related to the immune and vascular systems…
- Effect Ninhydrin–Copper-Peptide
“Synthesis and Characterization of Dicationic Gemini Surfactant Micelles and their Effect on the Rate of…